AMLX
AmylyxDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
AMLX vs peer average
44/100
AMLX vs. peer average (D vs. D)
Grade spread
A 2 · C 3 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANAB is the first available peer comparator.
AnaptysBio is a closer small-cap clinical-stage biotech valuation analog than a commercial pharma comp, with equity value largely driven by pipeline milestone timing rather than current earnings power; the comparison is useful for event-risk framing but not a direct indication match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AMLX
Amylyx
ANAB
AnaptysBio
Grade
D
C
Momentum
99
32
Value
41
50
Sentiment
41
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs ANAB
AMLX / ANAB
Grade Position
Below peers
AMLX vs. peer average (D vs. D)
44/100
Momentum
99
AMLXValue
41
ANABSentiment
41
ANABRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AMLX
ANAB is the first peer returned for this comparison set.